Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05724173 · ClinicalTrials.gov registry record · NA
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia
A NA study of Spinal Cord Injuries and Amyotrophic Lateral Sclerosis, sponsored by Leigh R. Hochberg, MD, PhD..
- Recruiting
- Registry status
- NA
- Development phase
- 3
- Enrollment target
- 2
- Study locations
NCT05724173: Recruiting NA study of Spinal Cord Injuries and Amyotrophic Lateral Sclerosis, sponsored by Leigh R. Hochberg, MD, PhD..
NCT05724173 is a NA study of Spinal Cord Injuries and Amyotrophic Lateral Sclerosis that is actively recruiting participants, run by Leigh R. Hochberg, MD, PhD.. The registered enrollment target is 3 participants, below the 62-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05724173, a NA study of Spinal Cord Injuries and Amyotrophic Lateral Sclerosis, is actively recruiting participants, sponsored by Leigh R. Hochberg, MD, PhD..
- RECRUITING
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to obtain preliminary device safety information and demonstrate proof of principle (feasibility) of the ability of people with tetraplegia to control a computer cursor and other assistive devices with their thoughts.
Primary Outcome
To determine the safety of the Sensor and overall safety of the System. Participants will be considered a success for this safety measure if they are successfully implanted with the Sensor(s) and: 1. the sensors are not explanted for safety reasons during the one-year post-implant evaluation period. 2. there are no device-related Serious Adverse Events that result in death or permanently increased disability during the one-year post-implant evaluation period.
Conditions Studied
Interventions
- DEVICE BrainGate Neural Interface System
Study Locations (2)
California
- Stanford University School of Medicine - Stanford
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2023-10-18 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT05724173 shows while recruiting
NCT05724173 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 62-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (95% lower).
The record links to 8 conditions, with Spinal Cord Injuries appearing as the primary indexed condition, and to 1 intervention - of which BrainGate Neural Interface System is the first listed.
NCT05724173 reports a single indexed study location in California, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05724173 about?
NCT05724173 is a clinical study titled "Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia". The purpose of this study is to obtain preliminary device safety information and demonstrate proof of principle (feasibility) of the ability of people with tetraplegia to control a computer cursor and other assistive devices with their thoughts.
What is the current status of trial NCT05724173?
This trial is currently recruiting. It is a NA study. The enrollment target is 3 participants. The study started on 2023-10-18. Estimated completion is 2026-12.
What conditions does trial NCT05724173 study?
This clinical trial studies the following conditions: Spinal Cord Injuries, Amyotrophic Lateral Sclerosis, Tetraplegia, Muscular Dystrophies, Dysarthria.
What interventions are being tested in trial NCT05724173?
The interventions under investigation include: BrainGate Neural Interface System (DEVICE).
Who is sponsoring clinical trial NCT05724173?
This trial is sponsored by Leigh R. Hochberg, MD, PhD., which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05724173 being conducted?
This trial has 2 study locations across California, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05724173's enrollment target sits among peer trials
3 200th of 202 higher than 3 of 202 other Spinal Cord Injuries trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spinal Cord Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
RECRUITING · NA
-
Closed-loop Spinal Stimulation for Restoration of Upper Extremity Function After Spinal Cord Injury
RECRUITING · NA
-
Neuromodulation to Improve Respiratory Function in Cervical Spinal Cord Injury
RECRUITING · NA
-
Transcutaneous Spinal Stimulation and Exercise for Locomotion
RECRUITING · NA
-
HAPPINESS: cHAnging the Perceived Pain INtEnSity in Populations With Spinal Cord Injury and With Health Disparities: A Feasibility Study
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy